Prevalence and risk factors of liver steatosis and fibrosis in patients with type 2 diabetes mellitus
Journal Title: Chinese Journal of Clinical Research - Year 2025, Vol 38, Issue 4
Abstract
Objective To summarize the occurrence of hepatic steatosis and hepatic fibrosis in patients with type 2 diabetes mellitus (T2DM), and to explore the related influencing factors. Methods A retrospective study was conducted on 697 T2DM patients hospitalized in Zhongda Hospital, Southeast University from November 2022 to January 2024. Liver steatosis and fibrosis were assessed using ultrasonic transient elastography, and multivariate logistic regression analysis was performed to identify the influencing factors of liver steatosis and fibrosis. Results The prevalence of hepatic steatosis in T2DM patients was 77.6% (541/697), with moderate to severe steatosis accounting for 54.1%; 36.0% (251/697) of patients presented with liver fibrosis, and 6.3% (44/697) were diagnosed with liver cirrhosis. Body mass index (BMI) (OR=1.407, 95%CI: 1.287-1.539), triglyceride (OR=1.393, 95%CI: 1.084-1.791), high density lipoprotein cholesterol (HDL-C) (OR=0.414, 95%CI: 0.189-0.907) were independent influencing factors for liver steatosis in T2DM patients (P＜0.05); BMI was an independent influencing factor for liver fibrosis in T2DM patients (OR=1.153, 95%CI: 1.088-1.221,P＜0.01). Conclusion The prevalence of liver steatosis and fibrosis is high in T2DM patients, with high BMI being the main risk factors for liver steatosis and fibrosis in T2DM patients, and poor blood lipid control being also the main risk factor for liver steatosis.
Authors and Affiliations
ZHANG Xiaoyan, YU Hekai, HAN Jing, SUN Weixia Department of Endocrinology, Zhongda Hospital, Southeast University, Nanjing, Jiangsu 210002, China
Keywords
Related Articles
- EP ID EP764827
- DOI 10.13429/j.cnki.cjcr.2025.04.012
- Views 8
- Downloads 0
Preliminary application of Acostream percutaneous aspiration thromboembolectomy sequential low-dose alteplase in the treatment of lower extremity deep vein thrombosis
Objectiv To investigate the efficacy and safety of Acostream percutaneous aspiration thromboembolectomy (PAT) sequential low-dose alteplase (rt-PA) in the treatment of lower extremity deep vein thrombosis(LEDVT). Method...
Effects of remimazolam, cipepofol and propofol on circulation during induction period of general anesthesia
Objective To observe the effects of remimazolam, cipepofol, and propofol on hemodynamics, blood glucose, and lactate levels during general anesthesia induction. Methods A total of 126 elective surgery patients at the Sec...
Effect of intravenous injection of different doses of lidocaine on cough during the recovery period after bronchoscopy under general anesthesia
Objective To evaluate the effect of intravenous injection of different doses of lidocaine on cough during the recovery period after bronchoscopy under general anesthesia, aiming to determine the optimal lidocaine dose. M...
Analysis of risk factors for delayed postoperative discharge of patients with pulmonary nodules
<b>Objective</b> To investigate the influencing factors of delayed postoperative discharge in patients with pulmonary nodules. <b>Methods</b> Electronic medical records of 223 patients, 91 males and 132 females, who...
Application of different approaches in interventional thrombolysis of deep vein thrombosis of lower extremities
Objective： To investigate the application effects of the popliteal vein approach versus the infrapatellar vein approach in interventional thrombolysis for the treatment of deep vein thrombosis (DVT) in the lower extrem...